Fellow in Clinical Pharmacology
Masters Level Graduate Student in Clinical Investigation, Clinical Scientist Training Program, Baylor College of Medicine
Dr. Holly Lindsay
6701 Fannin Street, Suite 1510.09
Houston, TX 77030
Dr. Holly Lindsay’s clinical interests lie in the treatment of children with brain tumors. She is a member of the Brain Tumor Program.
She is currently receiving specialized graduate level training in clinical research and pharmacology, as a part of the nationally-recognized Developmental Therapeutics Program at Texas Children’s Cancer and Hematology Centers.
Dr. Holly Lindsay’s research focuses on evaluating the role of targeted therapies for the treatment of childhood brain tumors. At present, Dr. Lindsay is conducting research in the laboratory of Xiao Nan-Li, MD, PhD where she currently works with mouse models. Her work has been presented at several national meetings.
Dr. Lindsay completed her internship and residency in pediatric medicine at the Children’s Hospital of Los Angeles before relocating to Houston, TX where she completed Baylor College of Medicine’s Fellowship Program in Pediatric Hematology/Oncology at Texas Children’s Hospital, the pediatric teaching hospital of Baylor College of Medicine. Her medical degree was awarded by Washington University, St. Louis School of Medicine. Prior to her medical training, she earned her Bachelor of Science in Chemistry and with an emphasis on Biochemistry and graduated Suma Cum Laude with Honors from Pacific Union College.
M.D., Washington University in St. Louis School of Medicine, St. Louis, MO Graduated May 2009
Residency in Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA Completed May 2012
Fellowship in Pediatric Hematology/Oncology, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX Completed June 2015
American Board of Pediatrics
American Academy of Pediatrics (AAP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
American Society of Pediatric Hematology/Oncology (ASPHO)
Children’s Oncology Group (COG)
Consultant to BCM IRB #5